236 related articles for article (PubMed ID: 32154926)
21. Quality of life 5 or more years post-autologous hematopoietic stem cell transplant.
Byar KL; Eilers JE; Nuss SL
Cancer Nurs; 2005; 28(2):148-57. PubMed ID: 15815185
[TBL] [Abstract][Full Text] [Related]
22. Health-Related Quality of Life in Double Umbilical Cord Blood versus Haploidentical Marrow Transplantation: A Quality of Life Analysis Report of BMT CTN 1101.
El Jurdi N; Martens MJ; Brunstein CG; O'Donnell P; Lee SJ; D'Souza A; Logan B; Hong S; Singh AK; Sandhu K; Shapiro RM; Horowitz MM; Hamilton BK
Transplant Cell Ther; 2023 Jul; 29(7):467.e1-467.e5. PubMed ID: 37088401
[TBL] [Abstract][Full Text] [Related]
23. Multimodal psychosocial intervention for family caregivers of patients undergoing hematopoietic stem cell transplantation: A randomized clinical trial.
El-Jawahri A; Jacobs JM; Nelson AM; Traeger L; Greer JA; Nicholson S; Waldman LP; Fenech AL; Jagielo AD; D'Alotto J; Horick N; Spitzer T; DeFilipp Z; Chen YA; Temel JS
Cancer; 2020 Apr; 126(8):1758-1765. PubMed ID: 31899552
[TBL] [Abstract][Full Text] [Related]
24. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
[TBL] [Abstract][Full Text] [Related]
25. Characterization of Pericarditis following Allogeneic Hematopoietic Cell Transplantation.
Freyer CW; Fradley M; Madnick D; Carver JR; Frey NV; Gill SI; Ky B; Luger SM; Martin ME; McCurdy SR; O'Quinn R; Perl AE; Stadtmauer EA; Loren AW
Transplant Cell Ther; 2021 Nov; 27(11):934.e1-934.e6. PubMed ID: 34339867
[TBL] [Abstract][Full Text] [Related]
26. Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of Life.
Kurosawa S; Yamaguchi T; Oshima K; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
Biol Blood Marrow Transplant; 2019 Sep; 25(9):1851-1858. PubMed ID: 31129353
[TBL] [Abstract][Full Text] [Related]
27. Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402).
Gooptu M; Kim HT; Howard A; Choi SW; Soiffer RJ; Antin JH; Ritz J; Cutler CS
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2143-2151. PubMed ID: 31271885
[TBL] [Abstract][Full Text] [Related]
28. Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns.
Wong FL; Francisco L; Togawa K; Bosworth A; Gonzales M; Hanby C; Sabado M; Grant M; Forman SJ; Bhatia S
Blood; 2010 Mar; 115(12):2508-19. PubMed ID: 20089962
[TBL] [Abstract][Full Text] [Related]
29. Improved disease-free-survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia.
Elmaagacli AH; Basoglu S; Peceny R; Trenschel R; Ottinger H; Lollert A; Runde V; Grosse-Wilde H; Beelen DW; Schaefer UW
Blood; 2002 Feb; 99(4):1130-5. PubMed ID: 11830457
[TBL] [Abstract][Full Text] [Related]
30. Post-transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: A report from the Center for International Blood and Marrow Transplant Research (CIBMTR).
Bhatt NS; Brazauskas R; Tecca HR; Carreras J; Burns LJ; Phelan R; Salit RB; Syrjala KL; Talano JM; Shaw BE
Cancer; 2019 Jan; 125(1):144-152. PubMed ID: 30368771
[TBL] [Abstract][Full Text] [Related]
31. Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902).
Wood WA; Le-Rademacher J; Syrjala KL; Jim H; Jacobsen PB; Knight JM; Abidi MH; Wingard JR; Majhail NS; Geller NL; Rizzo JD; Fei M; Wu J; Horowitz MM; Lee SJ
Cancer; 2016 Jan; 122(1):91-8. PubMed ID: 26439325
[TBL] [Abstract][Full Text] [Related]
32. The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System Analysis.
Arnold SD; Brazauskas R; He N; Li Y; Hall M; Atsuta Y; Dalal J; Hahn T; Khera N; Bonfim C; Hashmi S; Parsons S; Wood WA; Steinberg A; Freytes CO; Dandoy CE; Marks DI; Lazarus HM; Abdel-Azim H; Bitan M; Diaz MA; Olsson RF; Gergis U; Seber A; Wirk B; LeMaistre CF; Ustun C; Duncan C; Rizzieri D; Szwajcer D; Fagioli F; Frangoul H; Knight JM; Kamble RT; Mehta P; Schears R; Satwani P; Pulsipher MA; Aplenc R; Saber W
Biol Blood Marrow Transplant; 2020 Sep; 26(9):1747-1756. PubMed ID: 32464284
[TBL] [Abstract][Full Text] [Related]
33. Adherence to cancer screening guidelines in Australian survivors of allogeneic blood and marrow transplantation (BMT).
Dyer G; Larsen SR; Gilroy N; Brice L; Greenwood M; Hertzberg M; Kabir M; Brown L; Hogg M; Huang G; Moore J; Gottlieb D; Kwan J; Tan J; Ward C; Kerridge I
Cancer Med; 2016 Jul; 5(7):1702-16. PubMed ID: 27108674
[TBL] [Abstract][Full Text] [Related]
34. Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in Childhood.
Holmqvist AS; Chen Y; Wu J; Battles K; Bhatia R; Francisco L; Hageman L; Kung M; Ness E; Parman M; Salzman D; Wadhwa A; Winther JF; Rosenthal J; Forman SJ; Weisdorf DJ; Armenian SH; Arora M; Bhatia S
JAMA Oncol; 2018 Dec; 4(12):e182453. PubMed ID: 30054602
[TBL] [Abstract][Full Text] [Related]
35. Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium.
Pidala J; Kurland BF; Chai X; Vogelsang G; Weisdorf DJ; Pavletic S; Cutler C; Majhail N; Lee SJ
Haematologica; 2011 Oct; 96(10):1528-35. PubMed ID: 21685473
[TBL] [Abstract][Full Text] [Related]
36. Factors associated with changes in quality of life in patients undergoing allogeneic haematopoietic stem cell transplantation.
Kisch A; Lenhoff S; Zdravkovic S; Bolmsjö I
Eur J Cancer Care (Engl); 2012 Nov; 21(6):735-46. PubMed ID: 22519415
[TBL] [Abstract][Full Text] [Related]
37. Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.
Mehta RS; Peffault de Latour R; DeFor TE; Robin M; Lazaryan A; Xhaard A; Bejanyan N; de Fontbrune FS; Arora M; Brunstein CG; Blazar BR; Weisdorf DJ; MacMillan ML; Socie G; Holtan SG
Haematologica; 2016 Jun; 101(6):764-72. PubMed ID: 27036159
[TBL] [Abstract][Full Text] [Related]
38. Early versus late preemptive allogeneic hematopoietic cell transplantation for relapsed or refractory acute myeloid leukemia.
Chen GL; Liu H; Zhang Y; Thomas J; Ross M; Wang ES; Block AW; Sait S; Deeb G; Wallace P; Wetzler M; Hahn T; McCarthy PL
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1369-74. PubMed ID: 24867777
[TBL] [Abstract][Full Text] [Related]
39. Incorporating patient-reported outcome data into a predictive calculator for allogeneic hematopoietic cell transplantation recipients.
Shaw BE; Flynn KE; He N; Cusatis R; D'Souza A; Hamilton BK; Horowitz MM; Mattila D; Phelan R; Lee SJ; Brazauskas R
Cancer; 2024 May; 130(10):1826-1835. PubMed ID: 38198511
[TBL] [Abstract][Full Text] [Related]
40. Association Between Baseline Patient-Reported Outcomes and Complications of Hematopoietic Stem Cell Transplantation.
Johnson PC; Bhatt S; Reynolds MJ; Dhawale TM; Ufere N; Jagielo AD; Lavoie MW; Topping CEW; Clay MA; Rice J; Yi A; DeFilipp Z; Chen YB; El-Jawahri A
Transplant Cell Ther; 2021 Jun; 27(6):496.e1-496.e5. PubMed ID: 33789836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
